AVTX
Avalo Therapeutics·NASDAQ
--
--(--)
--
--(--)
AVTX fundamentals
Avalo Therapeutics (AVTX) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.92 (YoY +86.35%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-1.92
+86.35%
Report date
Aug 7, 2025
Earnings
EPS
Revenue
Revenue & Expenses
AVTX has released its 2025 Q4 earnings report, with revenue of 59.00K, reflecting a YoY change of -69.27%, and net profit of -13.72M, showing a YoY change of 61.18%. The Sankey diagram below clearly presents AVTX's revenue sources and cost distribution.
Key Indicators
Avalo Therapeutics (AVTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Avalo Therapeutics (AVTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Avalo Therapeutics (AVTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Avalo Therapeutics (AVTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Avalo Therapeutics (AVTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Avalo Therapeutics (AVTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Avalo Therapeutics’s earnings call?What were the key takeaways from Avalo Therapeutics's earnings call?What is Avalo Therapeutics's latest dividend and current dividend yield?What does Avalo Therapeutics do and what are its main business segments?What guidance did Avalo Therapeutics's management provide for the next earnings period?What factors drove the changes in Avalo Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Avalo Therapeutics year over year?Did Avalo Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
